Outset Medical (OM) Revenue Growth (3y) (2022 - 2026)
Outset Medical (OM) Revenue Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 0.73% |
| 10 | Outset Medical | 81,206.82 | -286.56 Mn | 12.10 Mn | -5.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.93% |
| Dec 31, 2025 | -3.38% |
| Sep 30, 2025 | 1.97% |
| Jun 30, 2025 | 7.83% |
| Mar 31, 2025 | -0.88% |
| Dec 31, 2024 | 1.53% |
| Sep 30, 2024 | 2.89% |
| Jun 30, 2024 | 2.79% |
| Mar 31, 2024 | 7.12% |
| Dec 31, 2023 | 20.94% |
| Sep 30, 2023 | 30.20% |
| Jun 30, 2023 | 45.33% |
| Mar 31, 2023 | 66.97% |
| Dec 31, 2022 | 65.31% |
| Sep 30, 2022 | 119.36% |